Alzheimer's Association International Conference

Healio brings you the highlights from the Alzheimer’s Association International Conference. Refer back to this page often for the latest news from AAIC, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Buprenorphine triples harmful adverse events in dementia

August 8, 2018
The commonly prescribed painkiller, buprenorphine, more than tripled psychiatric and neurological side effects among patients with dementia…
Meeting News

Hormone therapy not associated with cognitive harm in healthy women

August 3, 2018
When hormone therapy is initiated close to the start of menopause in healthy women without diabetes, it does not appear to be associated with any…
Meeting News

Alzheimer’s Association senior director discusses annual meeting highlights for PCPs

July 31, 2018
The first-ever guidelines for clinical evaluation of dementia in primary care, data that suggests a link between normal BP and cognitive decline, and…
Meeting News

Yoga meditation may prevent Alzheimer’s disease in women

July 27, 2018
Kirtan Kriya, a form of yoga meditation, improved cognitive function and may protect women against the development of Alzheimer’s disease…
Meeting News

Memantine fails to produce added benefit in combination therapy

July 26, 2018
Patients with mild-to-moderate-Alzheimer’s disease receiving monotherapy with acetylcholinesterase inhibitors reported cognitive and physical
Meeting News

Fruits, vegetables, lower risk for dementia, increase cognition

July 26, 2018
Different foods provided benefits associated with dementia, Alzheimer’s disease and cognition, according to several abstracts presented at the…
Meeting News

Reduced liver-synthesized lipids may increase Alzheimer’s risk

July 25, 2018
Reduced levels of plasmalogens synthesized in the liver may adversely affect central nervous system synaptic and antioxidant functions, potentially…
Meeting News

Compound shows significant potential as Alzheimer’s disease modifier

July 25, 2018
Bryostatin, a compound that showed an ability to induce synaptogenesis and prevent neuronal death in pretrials, now shows potential as a modifier of…
Meeting News

Synthetic cannabinoid may be effective for agitation in Alzheimer’s disease

July 25, 2018
Nabilone — a synthetic cannabinoid — reduced agitation and improved neuropsychiatric symptoms, cognition and nutrition in patients with…
Meeting News

Normal BP reduces risk for mild cognitive impairment

July 25, 2018
Patients at increased risk for CVD but without diabetes, who were treated to a systolic BP target of 120 mm Hg or less had significantly less risk…
Healio Jobs